Mark A. Lockwood
13Patents
4h-index
25Co-inventors
60Inventor score
Filing activity: Nov 7, 2002 → Jun 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9314468B2 | Chemokine receptor modulators | Chemistry; Metallurgy | 20 | Active |
| US9527881B2 | Steroid analogues for neuroprotection | Chemistry; Metallurgy | 8 | Active |
| US8338448B2 | Chemokine receptor modulators | Chemistry; Metallurgy | 5 | Active |
| US7189856B2 | Non-peptide somatostatin receptor ligands | Human Necessities | 4 | Expired |
| US10487109B2 | Progesterone phosphate analogs and uses related thereto | Emerging Cross-Sectional Technologies | 3 | Active |
| US9802978B2 | Progesterone phosphate analogs and uses related thereto | Emerging Cross-Sectional Technologies | 3 | Active |
| US11053276B2 | Progesterone phosphate analogs and uses related thereto | Emerging Cross-Sectional Technologies | 2 | Active |
| US10336787B2 | Progesterone analogs and uses related thereto | Emerging Cross-Sectional Technologies | 1 | Active |
| US11725025B2 | Progesterone phosphate analogs and uses related thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US11274118B2 | Progesterone analogs and uses related thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US7932245B2 | Spirocyclopropyl amides and acids and their therapeutic applications | Chemistry; Metallurgy | 0 | Expired |
| US12415829B2 | Progesterone phosphate analogs and uses related thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US10716795B2 | Steroid analogues for neuroprotection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.